While one study found via immunoblot of post mortem human epilepsy hippocampus samples a reduction of total brevican immunoreactivity (Favuzzi et al., 2017) a more recent study reported upregulated brevican levels in human post mortem frontal cortex samples from epilepsy patients as compared to controls (Pires et al., 2021). Here, BCAN is linked to epilepsy.